CDK 억제제 및 약제로서의 이의 용도
본 발명은 화학식 I의 화합물, 화학식 I의 화합물을 포함하는 약제학적 조성물에 관한 것이며, 이뿐만 아니라, 이들의 사용 및 제조 방법이 또한 기재된다. JPEGpct00352.jpg5578 The disclosure is directed to compounds of Formula IPharmaceutical compositions comprising compounds of Formula I, as well as methods of their use and preparation, are also described....
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | kor |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | BUESKING ANDREW W ZHUO JINCONG COMBS ANDREW PAUL PAWLEY SARAH WU XIAOWEI HOLMES RYAN |
| description | 본 발명은 화학식 I의 화합물, 화학식 I의 화합물을 포함하는 약제학적 조성물에 관한 것이며, 이뿐만 아니라, 이들의 사용 및 제조 방법이 또한 기재된다. JPEGpct00352.jpg5578
The disclosure is directed to compounds of Formula IPharmaceutical compositions comprising compounds of Formula I, as well as methods of their use and preparation, are also described. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_KR20230123919A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>KR20230123919A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_KR20230123919A3</originalsourceid><addsrcrecordid>eNrjZNB3dvFWeDNt65sFc4BI4fWGfoU3U_cCma8XznnTMufN3BkKb-ZuAVOzVr7ub-FhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfHeQUYGRsYGhkbGloaWjsbEqQIA_cY3Ww</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>CDK 억제제 및 약제로서의 이의 용도</title><source>esp@cenet</source><creator>BUESKING ANDREW W ; ZHUO JINCONG ; COMBS ANDREW PAUL ; PAWLEY SARAH ; WU XIAOWEI ; HOLMES RYAN</creator><creatorcontrib>BUESKING ANDREW W ; ZHUO JINCONG ; COMBS ANDREW PAUL ; PAWLEY SARAH ; WU XIAOWEI ; HOLMES RYAN</creatorcontrib><description>본 발명은 화학식 I의 화합물, 화학식 I의 화합물을 포함하는 약제학적 조성물에 관한 것이며, 이뿐만 아니라, 이들의 사용 및 제조 방법이 또한 기재된다. JPEGpct00352.jpg5578
The disclosure is directed to compounds of Formula IPharmaceutical compositions comprising compounds of Formula I, as well as methods of their use and preparation, are also described.</description><language>kor</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230824&DB=EPODOC&CC=KR&NR=20230123919A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76294</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230824&DB=EPODOC&CC=KR&NR=20230123919A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>BUESKING ANDREW W</creatorcontrib><creatorcontrib>ZHUO JINCONG</creatorcontrib><creatorcontrib>COMBS ANDREW PAUL</creatorcontrib><creatorcontrib>PAWLEY SARAH</creatorcontrib><creatorcontrib>WU XIAOWEI</creatorcontrib><creatorcontrib>HOLMES RYAN</creatorcontrib><title>CDK 억제제 및 약제로서의 이의 용도</title><description>본 발명은 화학식 I의 화합물, 화학식 I의 화합물을 포함하는 약제학적 조성물에 관한 것이며, 이뿐만 아니라, 이들의 사용 및 제조 방법이 또한 기재된다. JPEGpct00352.jpg5578
The disclosure is directed to compounds of Formula IPharmaceutical compositions comprising compounds of Formula I, as well as methods of their use and preparation, are also described.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNB3dvFWeDNt65sFc4BI4fWGfoU3U_cCma8XznnTMufN3BkKb-ZuAVOzVr7ub-FhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfHeQUYGRsYGhkbGloaWjsbEqQIA_cY3Ww</recordid><startdate>20230824</startdate><enddate>20230824</enddate><creator>BUESKING ANDREW W</creator><creator>ZHUO JINCONG</creator><creator>COMBS ANDREW PAUL</creator><creator>PAWLEY SARAH</creator><creator>WU XIAOWEI</creator><creator>HOLMES RYAN</creator><scope>EVB</scope></search><sort><creationdate>20230824</creationdate><title>CDK 억제제 및 약제로서의 이의 용도</title><author>BUESKING ANDREW W ; ZHUO JINCONG ; COMBS ANDREW PAUL ; PAWLEY SARAH ; WU XIAOWEI ; HOLMES RYAN</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_KR20230123919A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>kor</language><creationdate>2023</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>BUESKING ANDREW W</creatorcontrib><creatorcontrib>ZHUO JINCONG</creatorcontrib><creatorcontrib>COMBS ANDREW PAUL</creatorcontrib><creatorcontrib>PAWLEY SARAH</creatorcontrib><creatorcontrib>WU XIAOWEI</creatorcontrib><creatorcontrib>HOLMES RYAN</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>BUESKING ANDREW W</au><au>ZHUO JINCONG</au><au>COMBS ANDREW PAUL</au><au>PAWLEY SARAH</au><au>WU XIAOWEI</au><au>HOLMES RYAN</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>CDK 억제제 및 약제로서의 이의 용도</title><date>2023-08-24</date><risdate>2023</risdate><abstract>본 발명은 화학식 I의 화합물, 화학식 I의 화합물을 포함하는 약제학적 조성물에 관한 것이며, 이뿐만 아니라, 이들의 사용 및 제조 방법이 또한 기재된다. JPEGpct00352.jpg5578
The disclosure is directed to compounds of Formula IPharmaceutical compositions comprising compounds of Formula I, as well as methods of their use and preparation, are also described.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | kor |
| recordid | cdi_epo_espacenet_KR20230123919A |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | CDK 억제제 및 약제로서의 이의 용도 |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T18%3A02%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=BUESKING%20ANDREW%20W&rft.date=2023-08-24&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EKR20230123919A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |